FDA Approves Sacituzumab Govitecan for Pre-Treated HR+/HER2- Metastatic Breast Cancer
February 3rd 2023The approval is based on results from the phase 3 TROPiCS-02 trial demonstrating overall and progression survival benefits with sacituzumab govitecan compared with physician’s choice of single-agent chemotherapy.
Read More
Racial and Ethnic Disparities Persist in B-Cell ALL Survival in Children, Young Adults
February 3rd 2023Despite overall improvements in survival outcomes in recent decades, disparities in survival outcomes persist among children and young adults with acute lymphocytic leukemia (ALL) across racial and ethnic groups.
Read More
What We’re Reading: Eyedrops Recalled; Inaccessible Weight Loss Drugs; Doctor, GOP Governor Spar
February 3rd 2023CDC warns against EzriCare Artificial Tears, which were recalled by the manufacturer; certain weight loss drugs not covered by most payers; Mississippi's Republican governor denies being privately in support of Medicaid expansion.
Read More
Dr Paul Alexander: Community Partnerships Support RWJBarnabas’ Strategies Against Social Disparities
February 3rd 2023Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, discusses how community partnerships helped ameliorate disparities in health care access and accessibility, as well as food and travel insecurities amid the COVID-19 pandemic.
Watch
Dr Amy Crawford-Faucher Discusses RSV and Future Vaccines
February 3rd 2023Amy Crawford-Faucher, MD, vice chair of the Primary Care Institute and Department of Family Medicine at Allegheny Health Network, discussed treatment of respiratory syncytial virus (RSV) without a vaccine and what a future vaccine could mean for older adults.
Watch
AD Progression Adversely Influenced by Outdoor Air Pollution
February 2nd 2023With atopic dermatitis (AD) prevalence increasing around the world, primarily in developing countries, investigators evaluated the potential for pollution to have an impact on development of the chronic skin condition among an adult population.
Read More
Dr Edward Partridge: Prioritizing Social Determinants Key to Addressing Cancer Disparities
February 2nd 2023Edward Partridge, MD, chief medical officer of Guideway Care, spoke on his organization’s 25-year history in addressing cancer disparities and the crucial role that care navigators/guides have in achieving value-based care within oncology.
Watch
Merck & Co. and Eli Lilly & Co. report sales loss for COVID-19 treatments; Republican state attorneys general tell CVS and Walgreens that mailing mifepristone might break the law; exposure to air pollution over time is associated with a rise in incidence of depression and anxiety.
Read More
Periostin Bests Eosinophil Count for Biomarker Predictability in ECRS
February 2nd 2023Known to be a contributing factor to polyp development at high levels, periostin’s potential as a biomarker for eosinophilic chronic rhinosinusitis (ECRS) severity was investigated in a new study in which outcomes were compared between patients who had ECRS and those with non-ECRS.
Read More
International Panel Forms Consensus Best Practices for Active Surveillance in Prostate Cancer
February 1st 2023Health care expert and lived experience panels came to a consensus on several aspects that should be considered in the decision to offer and continue active surveillance for prostate cancer.
Read More
Study Suggests MRI Is the Best Breast Cancer Screening Modality for Dense Breasts
February 1st 2023A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.
Read More
Pharmaceutical companies will not refund prepayments made by global organization Gavi for COVID-19 vaccines it no longer needs; following the countrywide baby formula shortage of 2022, the FDA looks to consolidate food division leadership; a province in Canada starts a 3-year drug decriminalization program to try to reduce drug overdose deaths.
Read More
Contributor: How Improved Clinical Terminology Supports Efficient, Accurate Data Analytics
February 1st 2023Developing a terminology strategy that reflects real-world practice and industry standards can help data scientists and other allied data professionals efficiently and accurately identify clinically relevant insights that help improve the health of populations and individual patients.
Read More
Epilepsy Incidence, Prevalence Greater in More Deprived UK Regions
February 1st 2023Significant geographical variation was found regarding the prevalence and incidence of epilepsy in United Kingdom primary care data between 2013 and 2018, suggesting a potential relationship between the disease and deprivation.
Read More
Dr Terrance Mayes and Dr Loretta Erhunmwunsee Discuss Leadership Roles for NCCN Forum on Equity
January 31st 2023Terrance Mayes, EdD, and Loretta Erhunmwunsee, MD, FACS, discuss their new roles as chair and vice-chair, respectively, of the National Comprehensive Cancer Network’s (NCCN) new Diversity, Equity, & Inclusion (DEI) Directors Forum.
Read More